Literature DB >> 34159121

Pathologic von Willebrand factor degradation is a major contributor to left ventricular assist device-associated bleeding: pathophysiology and evolving clinical management.

Carlo R Bartoli1.   

Abstract

Entities:  

Year:  2021        PMID： 34159121      PMCID： PMC8185388          DOI： 10.21037/acs-2020-cfmcs-29

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN： 2225-319X


× No keyword cloud information.
  13 in total

1.  Mechanistic pathway(s) of acquired von willebrand syndrome with a continuous-flow ventricular assist device: in vitro findings.

Authors:  Sujith Dassanayaka; Mark S Slaughter; Carlo R Bartoli
Journal:  ASAIO J       Date:  2013 Mar-Apr       Impact factor: 2.872

2.  Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis.

Authors:  Carlo R Bartoli; David Zhang; Jooeun Kang; Samson Hennessy-Strahs; David Restle; Jessica Howard; Gretchen Redline; Christian Bermudez; Pavan Atluri; Michael A Acker
Journal:  Ann Thorac Surg       Date:  2017-09-21       Impact factor: 4.330

3.  Toward a Standard Practice to Quantify von Willebrand Factor Degradation During Left Ventricular Assist Device Support.

Authors:  Samson Hennessy-Strahs; Christian A Bermudez; Michael A Acker; Carlo R Bartoli
Journal:  Ann Thorac Surg       Date:  2020-11-20       Impact factor: 4.330

4.  Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal Angiodysplasia.

Authors:  Jooeun Kang; Samson Hennessy-Strahs; Pawel Kwiatkowski; Christian A Bermudez; Michael A Acker; Pavan Atluri; Patrick I McConnell; Carlo R Bartoli
Journal:  Circ Res       Date:  2017-07-20       Impact factor: 17.367

5.  Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.

Authors:  Carlo R Bartoli; David M Zhang; Samson Hennessy-Strahs; Jooeun Kang; David J Restle; Christian Bermudez; Pavan Atluri; Michael A Acker
Journal:  Circ Heart Fail       Date:  2018-09       Impact factor: 8.790

6.  Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.

Authors:  Jooeun Kang; David M Zhang; David J Restle; Faouzi Kallel; Michael A Acker; Pavan Atluri; Carlo R Bartoli
Journal:  J Thorac Cardiovasc Surg       Date:  2016-01-30       Impact factor: 5.209

7.  Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.

Authors:  Omar Wever-Pinzon; Craig H Selzman; Stavros G Drakos; Abdulfattah Saidi; Gregory J Stoddard; Edward M Gilbert; Mohamed Labedi; Bruce B Reid; Erin S Davis; Abdallah G Kfoury; Dean Y Li; Josef Stehlik; Feras Bader
Journal:  Circ Heart Fail       Date:  2013-03-11       Impact factor: 8.790

8.  Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.

Authors:  Carlo R Bartoli; Jooeun Kang; David J Restle; David M Zhang; Cameron Shabahang; Michael A Acker; Pavan Atluri
Journal:  JACC Heart Fail       Date:  2015-10-07       Impact factor: 12.035

Review 9.  von Willebrand factor regulation of blood vessel formation.

Authors:  Anna M Randi; Koval E Smith; Giancarlo Castaman
Journal:  Blood       Date:  2018-06-04       Impact factor: 22.113

10.  Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support.

Authors:  Flavien Vincent; Antoine Rauch; Valentin Loobuyck; Emmanuel Robin; Christoph Nix; André Vincentelli; David M Smadja; Pascal Leprince; Julien Amour; Gilles Lemesle; Hugues Spillemaeker; Nicolas Debry; Christian Latremouille; Piet Jansen; Antoine Capel; Mouhamed Moussa; Natacha Rousse; Guillaume Schurtz; Cédric Delhaye; Camille Paris; Emmanuelle Jeanpierre; Annabelle Dupont; Delphine Corseaux; Mickaël Rosa; Yoann Sottejeau; Svenja Barth; Claudia Mourran; Valérie Gomane; Augustin Coisne; Marjorie Richardson; Claudine Caron; Cristian Preda; Alexandre Ung; Alain Carpentier; Thomas Hubert; Cécile Denis; Bart Staels; Peter J Lenting; Eric Van Belle; Sophie Susen
Journal:  J Am Coll Cardiol       Date:  2018-05-15       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.